Androgenic hair loss. XII Diseases of the skin and subcutaneous tissue
Conditions
Interventions
Intervention 1: Intervention group: the group that receives standard treatment along with carboxytherapy. Intervention 2: Control group: The group receiving only standard treatment including minoxidi
Sponsors
Esfahan University of Medical Sciences
Eligibility
Sex/Gender
Male
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: Patients who are willing to participate in the study
Exclusion criteria
Exclusion criteria: _Patients suffering from other types of alopecia such as alopecia areata, telogen effluvium, anagen effluvium and alopeciaOscar winner2- Patients with psoriasis or lichen planus due to the positive Kübner phenomenon in these diseases.3- Any serious systemic diseases, including cancers, vascular collagen diseases, liver and kidney diseases, cardiovascular and thyroid diseases.4- Patients who have done hair transplant in the past
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Density and thickness of hair. Timepoint: The beginning of the study and the 3rd and 6th months of the study. Method of measurement: HANDY SCOPE FOTOFINDER Dermatoscope. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactHamzeh Shafiei
Esfahan University of Medical Sciences
Outcome results
None listed